Efficient resolution of Pneumocystis murina infection in surfactant protein A-deficient mice following withdrawal of corticosteroid-induced immunosuppression

J Med Microbiol. 2006 Feb;55(Pt 2):143-147. doi: 10.1099/jmm.0.46190-0.

Abstract

Following withdrawal of immunosuppression, surfactant protein A (SP-A)-deficient and wild-type mice cleared Pneumocystis murina infection in a similar manner, but exhibited significant differences in lymphocyte populations, interleukin (IL)-6 levels and chemokine expression levels. A higher percentage of lymphocytes were detected in lung lavage fluid from SP-A-deficient mice, but more CD4+ T cells were isolated from lung tissue of wild-type mice. Higher concentrations of IL-6 were detected in lavage fluid and enhanced expression of lymphotactin and RANTES were detected in the lungs of wild-type mice. Equal levels of surfactant protein D were detected in SP-A-deficient and wild-type mice and no differences were detected in markers of lung injury between the two strains of mice. Thus, SP-A does not enhance organism clearance, but does modulate the host immune response during resolution of P. murina infection.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Bronchoalveolar Lavage Fluid / immunology
  • CD4-Positive T-Lymphocytes / immunology
  • Cell Count
  • Chemokine CCL5 / analysis
  • Dexamethasone / administration & dosage
  • Immunocompromised Host*
  • Interleukin-6 / analysis
  • Lung / immunology
  • Lymphocytes / immunology
  • Lymphokines / analysis
  • Mice
  • Mice, Inbred C3H
  • Mice, Knockout
  • Pneumocystis*
  • Pneumonia, Pneumocystis / immunology*
  • Pulmonary Surfactant-Associated Protein A / deficiency*
  • Pulmonary Surfactant-Associated Protein A / genetics*
  • Sialoglycoproteins / analysis

Substances

  • Chemokine CCL5
  • Interleukin-6
  • Lymphokines
  • Pulmonary Surfactant-Associated Protein A
  • Sialoglycoproteins
  • lymphotactin
  • Dexamethasone